MALAT1 and neoplasm: Finally, NRF1 was found to bind to and transactivate MALAT1 promoter, providing evidence of a novel regulatory loop in MM cells, whose targeting by g#5 enhanced bortezomib anti-tumor activity both in drug sensitive and resistant MM cells.